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Convincing results on HLA Class II associations have been reported, however data on HLA class I association are limited and
inconsistent from studies in Leprosy. We present here the HLA A, B, and C allele distribution by molecular high resolution PCR-
SSOP technique in 32 leprosy patients compared with the 67 controls, from the same ethnic background. The signiﬁcant results
from the present study were a signiﬁcant increase in frequency of HLA A∗0206, A∗1102, B∗4016, B∗5110, Cw∗0407, and Cw∗0703
was observed when compared to controls. A striking decrease in the frequency of HLA A∗0101, Cw∗04011, and Cw∗0602 leprosy
patients was observed when compared to the controls. Further haplotype A∗1102-B∗4006-Cw∗1502 was signiﬁcantly increased
among the lepromatous leprosy patients when compared to the controls. It seems that HLA class I alleles play vital roles in disease
association/pathogenesis with leprosy among Indians.
INTRODUCTION
Genetic predisposition to both disease susceptibility
and host immune response has been postulated. Lep-
rosy disease burden currently is concentrated mainly in
six endemic countries; India, Brazil, Myanmar, Madagas-
car, Nepal, and Mozambique [1]. In India, about 64%
of leprosy prevalence and 78% of new case detection
of the worlds estimated 719330 cases occur [1]. Stud-
i e so nH u m a n sh a v es u g g e s t e dt h a th o s tg e n e t i c si si m -
portant in disease pathogenesis and protection [2]. With
the elucidation of genetics and structure of major his-
tocompatibility complex (MHC), T-cell receptor (TCR),
and peptide binding, the role of immune response (Ir)
genes and TCR in immune response are generally ac-
cepted to be important in active adaptive immunity [3].
The MHC restriction phenomenon has been explained
at the “consensus motif” level [4]. India is known for
her endogamous, ethnically distinct caste groups, char-
acterized by unique MHC haplotypes [5, 6]. Leprosy is
a chronic infectious disease caused by M. leprae,w h i c h
manifest as a clinical, pathological, and immunological
spectrum with paucibacillary tuberculoid leprosy (TT) at
one pole and the multibacillary disseminated leproma-
tous leprosy (LL) at the other extreme [7]. Epidemiologi-
cal studies suggest that only a small percentage of people
exposed to M. leprae get the disease, the majority are re-
sistant and develop eﬀective immunity which arrests the
growth of the bacteria at a subclinical stage [8]. Since
the ﬁrst studies in 1848 by Daulelson and Beck, many
investigators have attempted to establish a genetic factor
that would explain the familial spread of the disease [9].
Studies from India have revealed the HLA-DR2 antigen
associations in leprosy patients [10] whereas class I stud-
ies are limited. Earlier study from Mumbai in 1982 has
shown HLA-B40 association in lepromatous leprosy pa-
tients [11]. The present study was undertaken in order to
reveal the molecular subtype of the associations.
MATERIALS AND METHODS
Patientsandcontrols
Thirty-two leprosy patients attending the dermatol-
ogy clinic, in various hospitals in Mumbai, Maharas-
t r a ,w e r es t u d i e df o rH L AA ,B ,a n dCa l l e l e sa n dc o m -
pared with 67 unrelated healthy normal controls from
the same endemic region. All the patients included in
the study were HIV negative and were being treated with
chemotherapy. The controls did not show any clinical
symptoms of leprosy. The mean age of the controls was
40 years.
HLAtyping
Genomic DNA was extracted by sodium acetate
method [12] from 5ml of EDTA blood. These Genomic
DNA were genotyped for their A, B, and C allele sub-
types by polymerase chain reaction reverse line strip
sequence-speciﬁc oligonucleotide hybridization (PCR-
RLS-SSOP) strips (Roche Molecular, Oakland, Calif,
USA) [13]. Each strip for HLA A typing carried a to-
tal of 57 immobilized sequence-speciﬁc oligos (SSOs),
while the B carried a total of 84 immobilized SSOs. Ge-
nomic DNA was ampliﬁed using HLA A or HLA B locus2003:3 (2003) HLA Class I Association in Indian Leprosy Patients 209
Table 1. High risk HLA class I allele subtypes among the leprosy patients, Mumbai, India.
HLA
Total Controls
N = 32 N = 67
N+P F N+ PF OR Ki2 EF Pr F P value
A∗0101 2 0.0625 15 0.2230 0.231 3.965 0.17 0.04
A∗0203 5 0.1560 2 0.0298 6.018 5.265 0.13 0.02
A∗0206 7 0.2187 0 0.0000 0.000007∗∗
A∗1102 10 0.3120 1 0.0149 30.000 19.234 0.30 0.00001∗∗
B∗1801 6 0.1870 2 0.0298 7.500 8.140 0.16 0.007∗∗
B∗3520 7 0.2187 4 0.0597 4.410 5.546 0.16 0.01
B∗5110 9 0.2812 0 0.0000 0.0000005∗∗
B∗52011 6 0.1875 6 0.0890 2.346 1.950 0.10 0.16
Cw∗03031 1 0.0300 10 0.1490 0.183 3.053 0.12 0.08
Cw∗04011 1 0.0310 22 0.3280 0.065 10.718 0.30 0.001∗∗
Cw∗0407 14 0.4375 0 0.0000 0.000000001∗∗
Cw∗0602 4 0.1250 25 0.3730 0.240 6.437 0.28 0.01
Cw∗0703 8 0.2500 0 0.0000 0.000001∗∗
N+ Positive number OR Odds ratio
PF Phenotype frequency Pr F Preventive fraction
EF Etiological fraction ∗∗ Signiﬁcant P value
Ki2 Chi square with Yates correction
speciﬁc biotinylated primers and hybridized with the SSO
strips. Streptavidin-conjugated alkaline phosphatase was
used as a conjugate for positive color development us-
ing bromochloroindolyl phosphate/nitrobluetetrazolium
(BICP/NBT) in dimethylformamide (DMF) as a sub-
strate. The alleles were determined using the pattern in-
terpretation software supplied along with the kit.
Statisticalanalysis
The phenotype frequencies, odds ratio, probability
value, chi square with Yates correction, and aetiological
andpreventivefractionwereestimatedusingourdatabase
and computer programs as described earlier [14]. Since
each individual is tested for several HLA alleles and the
same data used for comparing the frequency; it is possible
that one of the alleles will by chance deviate signiﬁcantly.
To overcome this error, the P value is corrected by the use
of Bonferroni inequality method [15], that is, by multi-
plying it with the number of alleles compared.
RESULTS AND DISCUSSION
Some signiﬁcant ﬁndings can be concluded from this
study. (1) HLA A∗0101, Cw∗04011, and Cw∗0602 sub-
types were found to be negatively associated with lep-
rosy patients, when compared with controls (Table 1).
(2) A∗0206, A∗1102, B∗4016, B∗5110, Cw∗0407, and
Cw∗0703 alleles were associated with the leprosy pa-
tients when compared to controls. (Table 1). (3) Haplo-
type A∗1102-B∗4006-Cw∗1502 was found to be associ-
ated with lepromatous leprosy patients signiﬁcantly when
compared to controls. Various epidemiological studies in
the past have suggested that in prolonged contact with
lepromatous leprosy patients only less than 2% of the
contact develops Lepromatous leprosy. In the present
study, A∗1102-B∗4006-Cw∗1502 is correlated positively
and strongly with lepromatous leprosy, and this hap-
lotype constitutes less than 3% of the control popula-
tion as expected. Further DRB1 gene typing by PCR-
SSP typing revealed that 83% of these haplotypes were
found to posses DRB1∗1501 allele. Some of these as-
sociations and protection have not been previously de-
scribed in the leprosy patients studied from India. HLA
A∗1102, B∗1801, and B∗3520 were signiﬁcantly increased
when compared to the controls. It was interesting to note
that A∗2413, B∗0706, B∗4016, Cw∗0708, and Cw∗1505
were signiﬁcantly associated with the lepromatous lep-
rosy patients while they were not associated with tuber-
culoid type of leprosy when compared to controls. HLA
B∗5110, Cw∗0407, and Cw∗0703 were signiﬁcantly as-
sociated with leprosy patients while A∗0206 was signif-
icantly associated with the tuberculoid leprosy patients
when compared to the controls. The signiﬁcant haplo-
types associated with the leprosy patients when compared
to the controls revealed that A∗1102-B∗4006-Cw∗1502
wasthesigniﬁcanthaplotypeassociatedwithlepromatous
leprosy (Table 2). Further haplotypes A∗1102-B∗4006-
Cw∗0407 and A∗0203-B∗4016-Cw∗0703 were increased
among both the lepromatous and tuberculoid type of lep-
rosy patients when compared to controls.210 U. Shankarkumar et al 2003:3 (2003)
Table 2. Two Signiﬁcant haplotypes associated with the leprosy patients, Mumbai, India.
Haplotype Percentage frequency
Control LL type OR P value BT type OR P value
N = 67 N = 16 N = 16
A∗11-B∗40 7.46 50.00 12.40 0.0001∗∗ 12.50 1.770 0.514
A∗1102-B∗4006-Cw∗1502 2.98 31.25 12.51 0.000025∗∗ 0.00 0.000 0.000
A∗1102-B∗4006-Cw∗0407 1.49 12.50 9.44 0.0037∗∗ 6.25 4.400 0.264
A∗02-B∗40 20.89 31.25 1.72 0.375 18.75 0.873 0.514
A∗0203-B∗4016-Cw∗0703 1.49 12.50 9.43 0.034 6.25 4.400 0.264
OR Odds ratio
∗∗ Signiﬁcant P value
Diﬀerences in disease susceptibility can be seen at the
level of individuals and populations. Genetic epidemiol-
ogy data indicates that there might be major suscepti-
bility genes that account for a signiﬁcant proportion of
genetic contribution to disease susceptibility. HLA loci
evolve very fast, probably as a result of selective pressure
frompathogens,andpolymorphismintheselocihasbeen
associated with altered susceptibility to infectious diseases
[16]. Nevertheless, convincing results have been obtained
from studies on HLA class II associations with leprosy
[10], however, data on HLA Class I associations is lim-
ited and inconsistent. In leprosy patients from Iran, HLA
B35 was increased, while A1 was decreased in leproma-
tous leprosy patients [17]. Leprosy patients from Thai-
land showed HLA B18 and B40 associations in lepro-
matous leprosy [18]. Haplotypes A2-B40, A11-B40, and
A24-B40 were frequent among South Indian leprosy pa-
tients [19]. HLA B40 was signiﬁcantly associated with
Mumbailepromatous leprosy patients [11]. HLAA11 and
A33 were increased among Korean leprosy patients [20].
HLA A11 was signiﬁcantly increased with erythema no-
dosum leprosum (ENL) leprosy patients from North In-
dia [21]. Lepromatous Leprosy patients from North In-
dia showed increased frequencies of HLA B60, DR2, DR8,
and DQw1 [22]. Increased frequencies of HLA A2, A11,
B40, and DR2 were observed among the leprosy patients
from South India [23]. Recently, HLA A9, A10, A32, B5,
B21, Bw4, Bw6, Cw1, and Cw2 were found to be sig-
niﬁcantly more frequent among Turkish leprosy patients
[24]. In all these earlier studies, the HLA were determined
by conventional techniques that might have resulted in
a lower resolution of HLA types. The development of
DNA-based HLA typing methods has improved the va-
lidity of HLA typing. We have employed the high resolu-
tion PCR-RLS-SSOP typing to deﬁne the HLA class I alle-
les among the Mumbai leprosy patients. Hence, we have
identiﬁed novel alleles associated with Mumbai leprosy
patients.
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